OSU - James Comprehensive Cancer Center

Columbus, Ohio 43210-1228

1 studies enrolling now · 4 studies all time

What they study most

Allogeneic Hematopoietic Stem Cell Transplantation, Hepatotoxicity, Solid Tumors, Tenosynovial Giant Cell Tumor

Studies at this site

• A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment — Recruiting now
• Avelumab Program Rollover Study — Running, not enrolling
• Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT — Completed
• A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) — Stopped early